HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
INESSS
All the posts published.
New INESSS Evaluation Fee Schedule
June 2, 2021
-
Market Access News
,
Publications
-
Posted by
Patrick Manfred
Read More →
Read More →
MORSE Consulting Releases 2021 Edition of the Canadian Reimbursement and Forecasting Timelines Report
May 4, 2021
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
April 2020 Update to The Canadian Reimbursement Trends & Timelines Report – Now Available
April 27, 2020
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
Summary of the CADTH Drug Portfolio Information Session November 2019
December 2, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
NEW Canadian Reimbursement Trends and Timelines Report – now available!
September 18, 2019
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
Potential Impact of PMPRB Changes from a Regulatory, HTA and Payer Perspective
August 21, 2019
-
Market Access News
,
Publications
-
Posted by
MORSE Team
Read More →
Read More →
CADTH Pharmaceutical Reviews Update – July 2019
August 16, 2019
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Significant Developments in Canadian Drugs for Rare Disease Policy
November 14, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Summary of the HC-HTA Alignment Webinar Sept. 2018
October 17, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
CADTH & INESSS Pilot Project: Joint Engagement with Clinical Specialists
September 14, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
A Comparison of Proposed INESSS and Current CADTH Evaluation Fees
March 6, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Quebec Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada
August 15, 2017
-
Publications
-
Posted by
MORSE Team
Read More →
Read More →
New Drug Submission Guidelines in Quebec
June 8, 2017
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
INESSS - Info and details on - MORSE Consulting Inc.
Private
Public
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
Private
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB